Loading…
Asahi Kasei Corporation has completed its recommended public cash offer for Calliditas Therapeutics, becoming the owner of 93.30% of all shares in the company.
“Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas”news.cision.com
Summarized from public sources; check the original articles before acting on it.